Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBC pharmacokinetic feasibility study of salbutamol and tobramycin in healthy volunteers and mild-moderate asthma
NL-OMON46822Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of salbutamol and tobramycin in asthma (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Cmax, tmax and 14 more. Started Jan 2018; status: active, not recruiting.
02
Drugs
salbutamoltobramycin
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON46822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46822.